Clinical Trial: FIB-4 Cut-Offs for Liver Fibrosis in Obese Endocrinology Patients

U.S., June 24 -- ClinicalTrials.gov registry received information related to the study (NCT07663188) titled 'FIB-4 Cut-Offs for Liver Fibrosis in Obese Endocrinology Patients' on June 17.

Brief Summary: This single-center, prospective observational study aims to assess the accuracy of FIB-4 cut-offs in identifying liver fibrosis in obese patients attending an endocrinology outpatient clinic in Italy.

All consecutive eligible patients undergo routine blood tests and liver elastography (FibroScan) as part of clinical practice; FIB-4 values will be calculated and compared with liver stiffness measurements to evaluate the performance of FIB-4 thresholds for directing patients to FibroScan and hepatology care.

Study Start Date: Sept. 01, 2026...